Iovance Biotherapeutics, Inc.
DE ˙ DB ˙ US4622601007
€3.31 ↓ -0.17 (-4.89%)
2026-06-04
주가
SecurityDE:2LB / Iovance Biotherapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership2,875,526 shares
Latest Disclosed Value $ 10,093,096
Northern Trust Corp reports 11.47% increase in ownership of 2LB / Iovance Biotherapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 2,875,526 shares of Iovance Biotherapeutics, Inc. (DE:2LB) valued at $8,248,446 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,579,594 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 11.47% during the quarter. The current value of the position is $9,517,991 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,875,526 295,932 11.47 10,093 43.33 0.0013
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,579,594 118,521 4.82 7,042 31.87 0.0009
2025-11-14 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,461,073 341,286 16.10 5,341 46.46 0.0007
2025-08-13 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,119,787 -223,776 -9.55 3,646 -53.28 0.0005
2025-05-13 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,343,563 -71,244 -2.95 7,804 -56.33 0.0012
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,414,807 166,231 7.39 17,870 -15.37 0.0025
2024-11-13 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,248,576 81,618 3.77 21,114 21.49 0.0035
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,166,958 -60,386 -2.71 17,379 -47.35 0.0029
2024-05-14 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,227,344 44,467 2.04 33,009 86.01 0.0057
2024-02-13 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,182,877 189,698 9.52 17,747 95.70 0.0032
2023-11-13 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,993,179 180,930 9.98 9,069 -28.92 0.0018
2023-08-11 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,812,249 516,454 39.86 12,758 61.15 0.0025
2023-05-15 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,295,795 -264,857 -16.97 7,917 -20.61 0.0016
2023-02-13 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,560,652 -19,290 -1.22 9,973 -34.11 0.0021
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,579,942 -17,155 -1.07 15,135 -14.16 0.0035
2022-08-12 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,597,097 999,410 167.21 17,632 77.17 0.0038
2022-05-13 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 597,687 -9,815 -1.62 9,952 -14.18 0.0018
2022-02-08 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 607,502 -14,712 -2.36 11,597 -24.42 0.0019
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 622,214 -37,492 -5.68 15,344 -10.61 0.0027
2021-08-13 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 659,706 -16,003 -2.37 17,166 -19.76 0.0030
2021-05-12 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 675,709 2,310 0.34 21,392 -31.53 0.0040
2021-02-11 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 673,399 -7,781 -1.14 31,245 39.34 0.0061
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 681,180 -12,731 -1.83 22,423 17.72 0.0049
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 693,911 -783,629 -53.04 19,048 -56.94 0.0045
2020-05-14 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,477,540 18,325 1.26 44,231 9.51 0.0127
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,459,215 -20,401 -1.38 40,390 49.99 0.0090
2019-11-13 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,479,616 88,015 6.32 26,929 -21.08 0.0064
2019-08-13 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,391,601 9,910 0.72 34,122 159.70 0.0081
2019-05-13 2019-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,381,691 25,304 1.87 13,139 9.46 0.0032
2019-02-12 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,356,387 289,091 27.09 12,004 -0.02 0.0034
2018-11-14 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,067,296 48,347 4.74 12,007 -7.94 0.0029
2018-09-18 2018-06-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,018,949 146,964 16.85 13,043 -11.49 0.0033
2018-08-14 2018-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,024,801 152,816 13,118
2018-05-09 2018-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 871,985 140,696 19.24 14,736 151.90 0.0038
2018-02-14 2017-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 731,289 82,294 12.68 5,850 16.28 0.0015
2017-11-13 2017-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 648,995 346,495 114.54 5,031 126.21 0.0013
2017-08-11 2017-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 302,500 -402,010 -57.06 2,224 -57.63 0.0006
2017-05-12 2017-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 704,510 43,066 6.51 5,249 14.18 0.0015
2017-02-13 2016-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 661,444 65,461 10.98 4,597 -6.28 0.0014
2016-11-09 2016-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 595,983 75,224 14.45 4,905 16.29 0.0015
2016-08-12 2016-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 520,759 -2,000 -0.38 4,218 58.87 0.0014
2016-08-19 2016-03-31 13F/A-1 LION BIOTECHNOLOGIES COM 53619R102 522,759 16,363 3.23 2,655 -32.10 0.0009
2016-05-13 2016-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 522,759 2,655
2016-02-12 2015-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 506,396 15,289 3.11 3,910 38.21 0.0013
2015-11-12 2015-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 491,107 491,107 2,829 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.